Bolt Biotherapeutics
(NASDAQ) BOLT
Bolt Biotherapeutics Financials at a Glance
Market Cap
$8.24M
Revenue (TTM)
$7.70M
Net Income (TTM)
$33.38M
EPS (TTM)
$-17.78
P/E Ratio
-0.24
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$4.50
Volume
15,626
Open
$4.41
Price
$4.50
Volume
15,626
Open
$4.41
Previous Close
$4.29
Daily Range
$4.29 - $4.72
52-Week Range
$3.91 - $9.25
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$4.50
Volume
15,626
Open
$4.41
Previous Close
$4.29
Daily Range
$4.29 - $4.72
52-Week Range
$3.91 - $9.25
BOLT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bolt Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
23
CEO
William P. Quinn, MBA
Website
www.boltbio.comHeadquarters
Redwood City, CA 94063, US
BOLT Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-80%
Return on Capital
-72%
Return on Assets
-59%
Earnings Yield
-4.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.24M
Shares Outstanding
1.92M
Volume
15.63K
Short Interest
0.00%
Avg. Volume
24.83K
Financials (TTM)
Gross Profit
$6.20M
Operating Income
$34.63M
EBITDA
$33.14M
Operating Cash Flow
$39.85M
Capital Expenditure
$72.00K
Free Cash Flow
$39.92M
Cash & ST Invst.
$27.50M
Total Debt
$22.96M
Bolt Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.50M
N/A
Gross Profit
$1.30M
+404.9%
Gross Margin
51.96%
N/A
Market Cap
$8.24M
N/A
Market Cap/Employee
$158.53K
N/A
Employees
52
N/A
Net Income
$6.63M
+58.4%
EBITDA
$5.35M
+65.5%
Quarterly Fundamentals
Net Cash
$4.55M
-79.4%
Accounts Receivable
$973.00K
-16.5%
Inventory
$0.00
N/A
Long Term Debt
$20.13M
-12.3%
Short Term Debt
$2.83M
+25.5%
Return on Assets
-58.81%
N/A
Return on Invested Capital
-71.68%
N/A
Free Cash Flow
$7.16M
+50.4%
Operating Cash Flow
$7.16M
+50.4%